Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre

被引:0
|
作者
Shouki Bazarbashi
Mohamed Aseafan
Tasnim Elgazzar
Maha Alkhayat
Abdulrahman Alghabban
Marwa I. Abdelgawad
Bader Alshamsan
Aisha Alshibany
Tusneem Elhassan
Ali Aljubran
Ahmed Alzahrani
Hindi Alhindi
Hussein Raef
机构
[1] Section of Medical Oncology,College of Medicine
[2] Oncology Center,Section of Medical Oncology, Department of Internal Medicine
[3] King Faisal Specialist Hospital and Research Center,Clinical Oncology Department
[4] Alfaisal University,Department of Medicine, College of Medicine
[5] Security Forces Hospital Program,Department of Pathology and Laboratory Medicine
[6] Assiut University,Section of Endocrinology, Department of Internal Medicine
[7] Qassim University,undefined
[8] Oncology Center,undefined
[9] King Faisal Specialist Hospital and Research Center,undefined
[10] King Faisal Specialist Hospital and Research Center,undefined
[11] King Faisal Specialist Hospital and Research Center,undefined
来源
BMC Endocrine Disorders | / 23卷
关键词
Neuroendocrine tumor; Gastroenteropancreatic; GEP-NET; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Catecholamine production in patients with gastroenteropancreatic neuroendocrine tumors
    Ciofu, A
    Baudin, E
    Chanson, P
    Cailleux, AF
    Comoy, E
    Sabourin, JC
    Ducreux, M
    Schaison, G
    Schlumberger, M
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1999, 140 (05) : 434 - 437
  • [22] Correlation between clinicopathological characteristics and the clinical prognosis of patients with gastroenteropancreatic neuroendocrine tumors
    Fan, Dongwei
    Li, Xuanhe
    Yu, Yousheng
    Wang, Xingliang
    Fang, Jun
    Huang, Cheng
    MOLECULAR AND CLINICAL ONCOLOGY, 2023, 19 (05)
  • [23] Treatment Patterns and Health Resource Use Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated at a Tertiary Referral Center
    Jalbert, Jessica J.
    Casciano, Roman
    Meng, Jie
    Brais, Lauren K.
    Pulgar, Sonia J.
    Berthon, Anthony
    Dinet, Jerome
    Kulke, Matthew H.
    ONCOLOGIST, 2020, 25 (04): : E644 - E650
  • [24] Proposal of a treatment algorithm for the management of gastroenteropancreatic neuroendocrine tumors
    Bajetta, Emilio
    TUMORI, 2010, 96 (05) : 852 - 855
  • [25] Molecular targeted therapies in the treatment of gastroenteropancreatic neuroendocrine tumors
    Capdevila, Jaume
    Salazar, Ramon
    TARGETED ONCOLOGY, 2009, 4 (04) : 287 - 296
  • [26] Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms
    Heetfeld, M.
    Chougnet, C. N.
    Olsen, I. H.
    Rinke, A.
    Borbath, I.
    Crespo, G.
    Barriuso, J.
    Pavel, M.
    O'Toole, D.
    Walter, T.
    ENDOCRINE-RELATED CANCER, 2015, 22 (04) : 657 - 664
  • [27] Treatment of gastroenteropancreatic neuroendocrine tumors with octreotide LAR.
    Tomassetti, P
    Migliori, M
    Lalli, S
    Corinaldesi, R
    Gullo, L
    GASTROENTEROLOGY, 2000, 118 (04) : A526 - A526
  • [28] HIGH-DOSE LANREOTIDE TREATMENT IN PATIENTS WITH METASTATIC NEUROENDOCRINE GASTROENTEROPANCREATIC TUMORS
    FAISS, S
    SCHERUBL, H
    RATH, U
    BONATH, T
    RIECKEN, EO
    WIEDENMANN, B
    GASTROENTEROLOGY, 1995, 108 (04) : A465 - A465
  • [29] Novel Therapeutic Agents for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors
    Pavel, M. E.
    Wiedenmann, B.
    HORMONE AND METABOLIC RESEARCH, 2011, 43 (12) : 844 - 853
  • [30] Molecular targeted therapies in the treatment of gastroenteropancreatic neuroendocrine tumors
    Jaume Capdevila
    Ramon Salazar
    Targeted Oncology, 2009, 4 : 287 - 296